Atossa Therapeutics
ATOS
$1.54
Share price
5.48%
Change (1 day)
116.90%
Change (1 year)
Categories
Atossa Therapeutics (ATOS) - P/B ratio
P/B ratio as of May 2024 : 1.86
According to Atossa Therapeutics's latest financial reports the company has a price-to-book ratio of 1.86.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Atossa Therapeutics - P/B ratio (from 2012 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.12 | 97.83% |
| 2022-12-31 | 0.5673 | -61.32% |
| 2021-12-31 | 1.47 | -11.79% |
| 2020-12-31 | 1.66 | 52.59% |
| 2019-12-31 | 1.09 | 60.89% |
| 2018-12-31 | 0.6773 | -43.85% |
| 2017-12-31 | 1.21 | -30.06% |
| 2016-12-31 | 1.72 | -38.25% |
| 2015-12-31 | 2.79 | -24.48% |
| 2014-12-31 | 3.70 | -9.01% |
| 2013-12-31 | 4.06 | -58.25% |
| 2012-12-31 | 9.74 | |
| 2011-12-31 | N/A | |
| 2010-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.20 | 179.14% | 🇺🇸 USA |
 Quest Diagnostics
DGX | 2.39 | 28.31% | 🇺🇸 USA |
 LabCorp LH | 2.22 | 19.42% | 🇺🇸 USA |
 NeoGenomics
NEO | 2.16 | 16.10% | 🇺🇸 USA |
 Enzo Biochem ENZ | 0.7889 | -57.63% | 🇺🇸 USA |